STATE OF THE ART PAPER
Figure from article: Artificial intelligence in...
 
KEYWORDS
TOPICS
ABSTRACT
Artificial Intelligence (AI) could be integrated into Primary Health Care (PHC) to enhance the preventive care of several diseases. This scoping review aims to provide current evidence on AI applications for the prevention of non-infectious diseases in PHC. A structured search was conducted in PubMed/Medline and Scopus databases to identify studies evaluating AI-based interventions implemented in the preventive care of non-infectious diseases in the PHC sector. AI-supported preventive care was compared to standard preventive care or non-AI-based interventions. Preventive medicine was defined as at least one primary outcome related to disease incidence, risk reduction, and early detection rates of non-infectious diseases. AI demonstrates significant potential in preventive medicine in PHC as it enables proactive, personalized, and data-driven interventions. However, its adoption requires strategies to overcome technical, ethical, and organizational barriers. Future research should address real-world implementation, cost-effectiveness, and clinician engagement to maximize clinical impact.
REFERENCES (21)
1.
Katsakiori PF, Kagadis GC, Mulita F, Marangos M. Implementing artificial intelligence in family medicine: challenges and limitations. Cureus 2024; 16: e75518.
 
2.
Katonai G, Arvai N, Mesko B. AI and primary care: scoping review. J Med Internet Res 2025; 27: e65950.
 
3.
Yousefi F, Dehnavieh R, Laberge M, et al. Opportunities, challenges, and requirements for Artificial Intelligence (AI) implementation in Primary Health Care (PHC): a systematic review. BMC Prim Care 2025; 26: 196.
 
4.
Papachristou K, Katsakiori PF, Papadimitroulas P, Strigari L, Kagadis GC. Digital twins’ advancements and applications in healthcare, towards precision medicine. J Pers Med 2024; 14: 1101.
 
5.
Boutilier JJ, Chan TCY, Ranjan M, Deo S. Risk stratification for early detection of diabetes and hypertension in resource-limited settings: machine learning analysis. J Med Internet Res 2021; 23: e20123.
 
6.
Estiko RI, Widyantoro B, Juzar DA, Yusup RM, Rakhmat IF, Rijanto E. Screening hypertension using non-laboratory risk factors with machine learning: a retrospective cross-sectional study in Indonesia. BMJ Open 2025; 15: e092364.
 
7.
Fuller SD, Hu J, Liu JC, et al. Five-year cost-effectiveness modeling of primary care-based, nonmydriatic automated retinal image analysis screening among low-income patients with diabetes. J Diabetes Sci Technol 2022; 16: 415-27.
 
8.
Chima S, Martinez-Gutierrez J, Hunter B, et al. Future Health Today and patients at risk of undiagnosed cancer: a pragmatic cluster randomised trial of quality- improvement activities in general practice. Br J Gen Pract 2025; 75: e306-15.
 
9.
Elliott TE, Asche SE, O’Connor PJ, et al. Clinical decision support with or without shared decision making to improve preventive cancer care: a cluster-randomized trial. Med Decis Making 2022; 42: 808-21.
 
10.
Emery JD, Jenkins MA, Saya S, et al. The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening. Br J Gen Pract 2023; 73: e556-65.
 
11.
Gu C, Wang Y, Jiang Y, et al. Application of artificial intelligence system for screening multiple fundus diseases in Chinese primary healthcare settings: a real-world, multicentre and cross-sectional study of 4795 cases. Br J Ophthalmol 2024; 108: 424-31.
 
12.
Hill NR, Groves L, Dickerson C, et al. Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England. J Med Econ 2022; 25: 974-83.
 
13.
Liu J, Gibson E, Ramchal S, et al. Diabetic retinopathy screening with automated retinal image analysis in a primary care setting improves adherence to ophthalmic care. Ophthalmol Retina 2021; 5: 71-7.
 
14.
Malhotra A, Rachet B, Bonaventure A, Pereira SP, Woods LM. Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data. PLoS One 2021; 16: e0251876.
 
15.
Chen KM, Zhao CS, Knapp A, et al. Targeted interventions lead to quality improvement in year 2 of an artificial intelligence-based diabetic retinopathy detection program in northern california. Retina 2025; doi: 10.1097/IAE.0000000000004499.
 
16.
Briggs E, de Kamps M, Hamilton W, Johnson O, McInerney CD, Neal RD. Machine learning for risk prediction of oesophago-gastric cancer in primary care: comparison with existing risk-assessment tools. Cancers 2022; 14: 5023.
 
17.
Liu S, McCoy AB, Aldrich MC, et al. Leveraging natural language processing to identify eligible lung cancer screening patients with the electronic health record. Int J Med Inform 2023; 177: 105136.
 
18.
Schut MC, Luik TT, Vagliano I, et al. Artificial intelligence for early detection of lung cancer in GPs’ clinical notes: a retrospective observational cohort study. Br J Gen Pract 2025; 75: e316-22.
 
19.
Shah A, Polascik TJ, George DJ, et al. Implementation and impact of a risk-stratified prostate cancer screening algorithm as a clinical decision support tool in a Primary Care Network. J Gen Intern Med 2021; 36: 92-9.
 
20.
Kinaszczuk A, Morales-Lara AC, Garzon-Siatoya WT, et al. Artificial intelligence tools for preconception cardiomyopathy screening among women of reproductive age. Ann Fam Med 2025; 23: 246-54.
 
21.
Bhuiyan A, Govindaiah A, Alauddin S, Otero-Marquez O, Smith RT. Combined automated screening for age-related macular degeneration and diabetic retinopathy in primary care settings. Ann Eye Sci 2021; 6: 12.
 
eISSN:2451-0629
Journals System - logo
Scroll to top